Visual Performance of Patients Implanted With a Multifocal IOL

NAActive, not recruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
CataractRefractive Lens Exchange
Interventions
DEVICE

AT ELANA

The device is CE-approved. The device is a posterior chamber multifocal intraocular lens (IOL) indicated for aphakia after surgical extraction of the cataractous natural lens. The device is also indicated for non-cataractous, presbyopic patients (PRELEX) who seek greater independence from glasses for intermediate and/or near distances. It is an aspheric (aberration-neutral) IOL made of hydrophobic acrylic material, coated with heparin with modified C-loop haptics.

Trial Locations (3)

48429

PVK Precise Vision GmbH, Rheine

69120

Universitätsklinikum Heidelberg, Heidelberg

03001

Ofatlivist Alicante, Alicante

Sponsors
All Listed Sponsors
lead

Carl Zeiss Meditec AG

INDUSTRY

NCT06111222 - Visual Performance of Patients Implanted With a Multifocal IOL | Biotech Hunter | Biotech Hunter